Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EPIT.TA
- Price
- 805.20
- Stock movement up
- +56.20 (7.50%)
- Company name
- Epitomee Medical Ltd
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Medical Devices
- Market cap
- 23.96B
- Ent value
- 23.95B
- Price/Sales
- -
- Price/Book
- 688.55
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 154.65%
- 3 year return
- -34.12%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
EPIT.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 688.55 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 29.76M |
| EPS (TTM) | - |
| FCF per share (TTM) | -0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | 0.00 |
| Net income (TTM) | 0.00 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 15.63M |
| Net receivables | 0.00 |
| Total current assets | 35.06M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 13.09M |
| Total assets | 40.27M |
| Accounts payable | 544.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.96M |
| Total liabilities | 5.46M |
| Shareholder's equity | 34.80M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.66M |
| Capital expenditures (TTM) | 1.50M |
| Free cash flow (TTM) | -6.16M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | -17.69% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 800.00 |
| Daily high | 821.40 |
| Daily low | 800.00 |
| Daily Volume | 25K |
| All-time high | 4008.00 |
| 1y analyst estimate | - |
| Beta | 0.84 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EPIT.TA | S&P500 | |
| Current price drop from All-time high | -79.91% | -14.41% |
| Highest price drop | -93.62% | -56.47% |
| Date of highest drop | 12 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -68.87% | -11.07% |
| Avg time to new high | 822 days | 12 days |
| Max time to new high | 821 days | 1805 days |
COMPANY DETAILS
Marketcap
23.96B
Marketcap category
Large-cap
Description
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
Employees
42
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Epitomee Medical Ltd. (TASE: EPIT) announces that significant results from its RESET study on a novel oral hydrogel capsule for weight loss were presented at ObesityWeek® 2024. The prestigious event, ...
November 19, 2024
Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opport...
October 15, 2024
Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed ...
September 18, 2024